Eklira Genuair

Eklira Genuair is a medication containing Aclidinium Bromide, used for inhalation to manage respiratory conditions. It is designed to help improve breathing by relaxing the airways.

Eklira Genuair is primarily used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). This medication works by relaxing the muscles around the airways, making it easier to breathe. It is often prescribed for individuals who require long-term management of their respiratory symptoms.

Common effects of Eklira Genuair may include dry mouth, throat irritation, and coughing. Some users might experience headaches or dizziness. These effects are generally mild and temporary, but if they persist or worsen, it is advisable to consult a healthcare professional.

Eklira Genuair should be used with caution in individuals with certain medical conditions, such as heart problems or glaucoma. It is important to follow the prescribed dosage and administration instructions carefully. Always store the medication in a cool, dry place and keep it out of reach of children.

Eklira Genuair may interact with other medications, particularly those that affect the heart or respiratory system. It is important to inform your healthcare provider about all the medications you are taking to avoid potential interactions. Additionally, avoid using alcohol while taking this medication, as it may increase the risk of side effects.